BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 35752028)

  • 1. A predictive model based on liquid biopsy for non-small cell lung cancer to assess patient's prognosis: Development and application.
    Gu T; Ren J; Hu Z; Wei Y; Huang J
    Tissue Cell; 2022 Aug; 77():101854. PubMed ID: 35752028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Establishment of prognostic nomograms for predicting the progression free survival of EGFR-sensitizing mutation, advanced lung cancer patients treated with EGFR-TKIs.
    Du X; Bai H; Wang Z; Daun J; Liu Z; Xu J; Chang G; Zhu Y; Wang J
    Thorac Cancer; 2022 May; 13(9):1289-1298. PubMed ID: 35347870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel nomogram for predicting survival in advanced non-small cell lung cancer receiving anti-PD-1 plus chemotherapy with or without antiangiogenic therapy.
    Wu Y; Lv C; Lin M; Hong Y; Du B; Yao N; Zhu Y; Ji X; Li J; Lai J
    Front Immunol; 2023; 14():1297188. PubMed ID: 38022521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of prognostic factors and nomogram model for patients with advanced lung cancer receiving immune checkpoint inhibitors.
    Chen X; Li Z; Zhou J; Wei Q; Wang X; Jiang R
    PeerJ; 2022; 10():e14566. PubMed ID: 36540802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New biomarkers exploration and nomogram construction of prognostic and immune-related adverse events of advanced non-small cell lung cancer patients receiving immune checkpoint inhibitors.
    Lin X; Chen X; Long X; Zeng C; Zhang Z; Fang W; Xu P
    Respir Res; 2023 Feb; 24(1):64. PubMed ID: 36849947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Construction of the prognostic model for small-cell lung cancer based on inflammatory markers: A real-world study of 612 cases with eastern cooperative oncology group performance score 0-1.
    Liu C; Jin B; Liu Y; Juhua O; Bao B; Yang B; Liu X; Yu P; Luo Y; Wang S; Teng Z; Song N; Qu J; Zhao J; Chen Y; Qu X; Zhang L
    Cancer Med; 2023 Apr; 12(8):9527-9540. PubMed ID: 37015898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prognostic model for predicting progression-free survival in patients with advanced non-small cell lung cancer after image-guided microwave ablation plus chemotherapy.
    Kong F; Yang H; Wang Q; Wei Z; Ye X
    Eur Radiol; 2023 Nov; 33(11):7438-7449. PubMed ID: 37318606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A nomogram model for predicting the risk of checkpoint inhibitor-related pneumonitis for patients with advanced non-small-cell lung cancer.
    Zhang Y; Zhang L; Cao S; Wang Y; Ling X; Zhou Y; Zhong H
    Cancer Med; 2023 Aug; 12(15):15998-16010. PubMed ID: 37409360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predicting 5-Year Progression and Survival Outcomes for Early Stage Non-small Cell Lung Cancer Treated with Stereotactic Ablative Radiation Therapy: Development and Validation of Robust Prognostic Nomograms.
    Kang J; Ning MS; Feng H; Li H; Bahig H; Brooks ED; Welsh JW; Ye R; Miao H; Chang JY
    Int J Radiat Oncol Biol Phys; 2020 Jan; 106(1):90-99. PubMed ID: 31586665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new nomogram and risk classification system for predicting survival in small cell lung cancer patients diagnosed with brain metastasis: a large population-based study.
    Shan Q; Shi J; Wang X; Guo J; Han X; Wang Z; Wang H
    BMC Cancer; 2021 May; 21(1):640. PubMed ID: 34051733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrative nomogram of CT imaging, clinical, and hematological features for survival prediction of patients with locally advanced non-small cell lung cancer.
    Wang L; Dong T; Xin B; Xu C; Guo M; Zhang H; Feng D; Wang X; Yu J
    Eur Radiol; 2019 Jun; 29(6):2958-2967. PubMed ID: 30643940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nomograms for predicting disease progression in patients of Stage I non-small cell lung cancer treated with stereotactic body radiotherapy.
    Ye L; Shi S; Zeng Z; Huang Y; Hu Y; He J
    Jpn J Clin Oncol; 2018 Feb; 48(2):160-166. PubMed ID: 29253245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A nomogram to predict survival in non-small cell lung cancer patients treated with nivolumab.
    Botticelli A; Salati M; Di Pietro FR; Strigari L; Cerbelli B; Zizzari IG; Giusti R; Mazzotta M; Mazzuca F; Roberto M; Vici P; Pizzuti L; Nuti M; Marchetti P
    J Transl Med; 2019 Mar; 17(1):99. PubMed ID: 30917841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a radiomics nomogram based on the 2D and 3D CT features to predict the survival of non-small cell lung cancer patients.
    Yang L; Yang J; Zhou X; Huang L; Zhao W; Wang T; Zhuang J; Tian J
    Eur Radiol; 2019 May; 29(5):2196-2206. PubMed ID: 30523451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic factors and nomogram for cancer-specific death in non small cell lung cancer with malignant pericardial effusion.
    Hu ZG; Hu K; Li WX; Zeng FJ
    PLoS One; 2019; 14(5):e0217007. PubMed ID: 31095610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and Validation of a Novel Survival Prediction Model in Patients With Spinal Metastasis From Non-small Cell Lung Cancer.
    Yang M; Xu W; Liu T; Yang X; Wang P; Wu S; Wei H; Zhao J; Yang C; Xiao J
    Spine (Phila Pa 1976); 2019 Feb; 44(4):246-257. PubMed ID: 30059487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and validation of nomograms for predicting survival of elderly patients with stage I small-cell lung cancer.
    Yang Y; Sun S; Wang Y; Xiong F; Xiao Y; Huang J
    Bosn J Basic Med Sci; 2021 Oct; 21(5):632-641. PubMed ID: 33577444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A prognostic nomogram for metastasized colorectal cancer patients treated with cetuximab].
    Zhong LP; Li D; Zhu LZ; Fang XF; Xiao Q; Ding KF; Yuan Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Jul; 23(7):701-708. PubMed ID: 32683833
    [No Abstract]   [Full Text] [Related]  

  • 19. Radiotranscriptomics signature-based predictive nomograms for radiotherapy response in patients with nonsmall cell lung cancer: Combination and association of CT features and serum miRNAs levels.
    Fan L; Cao Q; Ding X; Gao D; Yang Q; Li B
    Cancer Med; 2020 Jul; 9(14):5065-5074. PubMed ID: 32458566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A nomogram from the SEER database for predicting the prognosis of patients with non-small cell lung cancer.
    Zeng B; Ji P; Chen C; Sun J; Gu C; Shang A; Wu J; Sun Z; Li D
    Int J Biochem Cell Biol; 2020 Oct; 127():105825. PubMed ID: 32898690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.